BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jászberényi M, Bujdosó E, Pataki I, Telegdy G. Effects of orexins on the hypothalamic-pituitary-adrenal system. J Neuroendocrinol 2000;12:1174-8. [PMID: 11106974 DOI: 10.1046/j.1365-2826.2000.00572.x] [Cited by in Crossref: 127] [Cited by in F6Publishing: 132] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Vogel V, Sanchez C, Jennum P. EEG measurements by means of radiotelemetry after intracerebroventricular (ICV) cannulation in rodents. Journal of Neuroscience Methods 2002;118:89-96. [DOI: 10.1016/s0165-0270(02)00148-6] [Cited by in Crossref: 25] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
2 Srinivasan S, Shariff M, Bartlett SE. The role of the glucocorticoids in developing resilience to stress and addiction. Front Psychiatry 2013;4:68. [PMID: 23914175 DOI: 10.3389/fpsyt.2013.00068] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
3 Palotai M, Telegdy G, Jászberényi M. Orexin A-induced anxiety-like behavior is mediated through GABA-ergic, α- and β-adrenergic neurotransmissions in mice. Peptides 2014;57:129-34. [DOI: 10.1016/j.peptides.2014.05.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
4 Recourt K, de Boer P, Zuiker R, Luthringer R, Kent J, van der Ark P, Van Hove I, van Gerven J, Jacobs G, van Nueten L, Drevets W. The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder. Transl Psychiatry 2019;9:216. [PMID: 31481683 DOI: 10.1038/s41398-019-0553-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
5 Winsky-Sommerer R, Boutrel B, de Lecea L. Stress and arousal: the corticotrophin-releasing factor/hypocretin circuitry. Mol Neurobiol 2005;32:285-94. [PMID: 16385142 DOI: 10.1385/MN:32:3:285] [Cited by in Crossref: 91] [Cited by in F6Publishing: 52] [Article Influence: 5.7] [Reference Citation Analysis]
6 Nixon JP, Kotz CM, Novak CM, Billington CJ, Teske JA. Neuropeptides controlling energy balance: orexins and neuromedins. Handb Exp Pharmacol 2012;:77-109. [PMID: 22249811 DOI: 10.1007/978-3-642-24716-3_4] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
7 Katahira H, Sunagawa M, Watanabe D, Kanada Y, Katayama A, Yamauchi R, Takashima M, Ishikawa S, Hisamitsu T. Antistress effects of Kampo medicine "Yokukansan" via regulation of orexin secretion. Neuropsychiatr Dis Treat 2017;13:863-72. [PMID: 28360524 DOI: 10.2147/NDT.S129418] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
8 Grafe LA, Eacret D, Luz S, Gotter AL, Renger JJ, Winrow CJ, Bhatnagar S. Orexin 2 receptor regulation of the hypothalamic-pituitary-adrenal (HPA) response to acute and repeated stress. Neuroscience 2017;348:313-23. [PMID: 28257896 DOI: 10.1016/j.neuroscience.2017.02.038] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 5.6] [Reference Citation Analysis]
9 Smith PM, Samson WK, Ferguson AV. Cardiovascular actions of orexin-A in the rat subfornical organ. J Neuroendocrinol 2007;19:7-13. [PMID: 17184481 DOI: 10.1111/j.1365-2826.2006.01497.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
10 Silveyra P, Cataldi NI, Lux-Lantos VA, Libertun C. Role of orexins in the hypothalamic-pituitary-ovarian relationships. Acta Physiol (Oxf) 2010;198:355-60. [PMID: 19796256 DOI: 10.1111/j.1748-1716.2009.02049.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 2.3] [Reference Citation Analysis]
11 Bernier NJ. The corticotropin-releasing factor system as a mediator of the appetite-suppressing effects of stress in fish. General and Comparative Endocrinology 2006;146:45-55. [DOI: 10.1016/j.ygcen.2005.11.016] [Cited by in Crossref: 127] [Cited by in F6Publishing: 118] [Article Influence: 7.9] [Reference Citation Analysis]
12 Aguilera G. Regulation of the hypothalamic-pituitary-adrenal axis by neuropeptides. Horm Mol Biol Clin Investig 2011;7:327-36. [PMID: 25961271 DOI: 10.1515/HMBCI.2011.123] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
13 García MC, López M, Gualillo O, Seoane LM, Diéguez C, Señarís RM. Hypothalamic levels of NPY, MCH, and prepro‐orexin mRNA during pregnancy and lactation in the rat: role of prolactin. FASEB j 2003;17:1392-400. [DOI: 10.1096/fj.02-0933com] [Cited by in Crossref: 81] [Cited by in F6Publishing: 73] [Article Influence: 4.3] [Reference Citation Analysis]
14 Stricker-Krongrad A, Beck B. Modulation of hypothalamic hypocretin/orexin mRNA expression by glucocorticoids. Biochem Biophys Res Commun. 2002;296:129-133. [PMID: 12147238 DOI: 10.1016/S0006-291X(02)00848-3] [Cited by in Crossref: 41] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
15 Pate AT, Yosten GL, Samson WK. Neuropeptide W increases mean arterial pressure as a result of behavioral arousal. Am J Physiol Regul Integr Comp Physiol 2013;305:R804-10. [PMID: 23926134 DOI: 10.1152/ajpregu.00119.2013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
16 Pavlidis M, Sundvik M, Chen Y, Panula P. Adaptive changes in zebrafish brain in dominant–subordinate behavioral context. Behavioural Brain Research 2011;225:529-37. [DOI: 10.1016/j.bbr.2011.08.022] [Cited by in Crossref: 68] [Cited by in F6Publishing: 67] [Article Influence: 6.2] [Reference Citation Analysis]
17 Tyree SM, Borniger JC, de Lecea L. Hypocretin as a Hub for Arousal and Motivation. Front Neurol 2018;9:413. [PMID: 29928253 DOI: 10.3389/fneur.2018.00413] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 9.3] [Reference Citation Analysis]
18 Acuna-Goycolea C, van den Pol AN. Neuroendocrine proopiomelanocortin neurons are excited by hypocretin/orexin. J Neurosci 2009;29:1503-13. [PMID: 19193897 DOI: 10.1523/JNEUROSCI.5147-08.2009] [Cited by in Crossref: 39] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
19 Yeoh JW, Campbell EJ, James MH, Graham BA, Dayas CV. Orexin antagonists for neuropsychiatric disease: progress and potential pitfalls. Front Neurosci 2014;8:36. [PMID: 24616658 DOI: 10.3389/fnins.2014.00036] [Cited by in Crossref: 59] [Cited by in F6Publishing: 59] [Article Influence: 7.4] [Reference Citation Analysis]
20 Grafe LA, Geng E, Corbett B, Urban K, Bhatnagar S. Sex- and Stress-Dependent Effects on Dendritic Morphology and Spine Densities in Putative Orexin Neurons. Neuroscience 2019;418:266-78. [PMID: 31442567 DOI: 10.1016/j.neuroscience.2019.08.026] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
21 Ito N, Yabe T, Gamo Y, Nagai T, Oikawa T, Yamada H, Hanawa T. I.c.v. administration of orexin-A induces an antidepressive-like effect through hippocampal cell proliferation. Neuroscience 2008;157:720-32. [DOI: 10.1016/j.neuroscience.2008.09.042] [Cited by in Crossref: 67] [Cited by in F6Publishing: 64] [Article Influence: 4.8] [Reference Citation Analysis]
22 Overeem S, Mignot E, van Dijk JG, Lammers GJ. Narcolepsy: clinical features, new pathophysiologic insights, and future perspectives. J Clin Neurophysiol 2001;18:78-105. [PMID: 11435802 DOI: 10.1097/00004691-200103000-00002] [Cited by in Crossref: 217] [Cited by in F6Publishing: 164] [Article Influence: 10.3] [Reference Citation Analysis]
23 Nishino S, Yoshida Y. History and perspectives of hypocretin/orexin research in sleep medicine. Sleep and Biological Rhythms 2003;1:43-54. [DOI: 10.1046/j.1446-9235.2003.00001.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
24 Nishino S, Ripley B, Mignot E, Benson KL, Zarcone VP. CSF hypocretin-1 levels in schizophrenics and controls: relationship to sleep architecture. Psychiatry Research 2002;110:1-7. [DOI: 10.1016/s0165-1781(02)00032-x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
25 Graebner AK, Iyer M, Carter ME. Understanding how discrete populations of hypothalamic neurons orchestrate complicated behavioral states. Front Syst Neurosci 2015;9:111. [PMID: 26300745 DOI: 10.3389/fnsys.2015.00111] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
26 Hirose M, Egashira S, Goto Y, Hashihayata T, Ohtake N, Iwaasa H, Hata M, Fukami T, Kanatani A, Yamada K. N-acyl 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline: the first orexin-2 receptor selective non-peptidic antagonist. Bioorg Med Chem Lett 2003;13:4497-9. [PMID: 14643355 DOI: 10.1016/j.bmcl.2003.08.038] [Cited by in Crossref: 77] [Cited by in F6Publishing: 72] [Article Influence: 4.3] [Reference Citation Analysis]
27 Bruijnzeel AW. Tobacco addiction and the dysregulation of brain stress systems. Neurosci Biobehav Rev 2012;36:1418-41. [PMID: 22405889 DOI: 10.1016/j.neubiorev.2012.02.015] [Cited by in Crossref: 100] [Cited by in F6Publishing: 92] [Article Influence: 10.0] [Reference Citation Analysis]
28 Sugimoto K, Ohmomo H, Shutoh F, Nogami H, Hisano S. Presentation of noise during acute restraint stress attenuates expression of immediate early genes and arginine vasopressin in the hypothalamic paraventricular nucleus but not corticosterone secretion in rats. Neurosci Res 2015;96:20-9. [PMID: 25496933 DOI: 10.1016/j.neures.2014.11.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
29 Novikova NS, Perekrest SV, Shainidze KZ, Korneva EA. Hypothalamic Orexin-Containing Neurons in the Hypothalamus on Exposure to Antigenic and Non-Antigenic Stimuli. Neurosci Behav Physi 2011;41:188-97. [DOI: 10.1007/s11055-011-9399-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
30 Beuckmann CT, Ueno T, Nakagawa M, Suzuki M, Akasofu S. Preclinical in vivo characterization of lemborexant (E2006), a novel dual orexin receptor antagonist for sleep/wake regulation. Sleep 2019;42:zsz076. [PMID: 30923834 DOI: 10.1093/sleep/zsz076] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
31 Follwell MJ, Ferguson AV. Cellular mechanisms of orexin actions on paraventricular nucleus neurones in rat hypothalamus. J Physiol 2002;545:855-67. [PMID: 12482891 DOI: 10.1113/jphysiol.2002.030049] [Cited by in Crossref: 65] [Cited by in F6Publishing: 61] [Article Influence: 3.4] [Reference Citation Analysis]
32 Magdaleno-madrigal VM, Morales-mulia S, Nicolini H, Genis-mendoza A, Cázares-martínez Claudia E, Pérez-luna José M, Morales-mulia M. Orexin-A promotes EEG changes but fails to induce anxiety in rats. Behavioural Brain Research 2019;361:26-31. [DOI: 10.1016/j.bbr.2018.12.037] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
33 Chang H, Saito T, Ohiwa N, Tateoka M, Deocaris CC, Fujikawa T, Soya H. Inhibitory effects of an orexin-2 receptor antagonist on orexin A- and stress-induced ACTH responses in conscious rats. Neurosci Res 2007;57:462-6. [PMID: 17188385 DOI: 10.1016/j.neures.2006.11.009] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 3.1] [Reference Citation Analysis]
34 Ciriello J, McMurray JC, Babic T, de Oliveira CV. Collateral axonal projections from hypothalamic hypocretin neurons to cardiovascular sites in nucleus ambiguus and nucleus tractus solitarius. Brain Res 2003;991:133-41. [PMID: 14575885 DOI: 10.1016/j.brainres.2003.08.016] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 3.0] [Reference Citation Analysis]
35 Kuwaki T, Zhang W. Orexin neurons as arousal-associated modulators of central cardiorespiratory regulation. Respiratory Physiology & Neurobiology 2010;174:43-54. [DOI: 10.1016/j.resp.2010.04.018] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 2.9] [Reference Citation Analysis]
36 López M, Tena-Sempere M, Diéguez C. Cross-talk between orexins (hypocretins) and the neuroendocrine axes (hypothalamic-pituitary axes). Front Neuroendocrinol 2010;31:113-27. [PMID: 19654017 DOI: 10.1016/j.yfrne.2009.07.001] [Cited by in Crossref: 52] [Cited by in F6Publishing: 45] [Article Influence: 4.0] [Reference Citation Analysis]
37 Ford GK, Al-barazanji KA, Wilson S, Jones DNC, Harbuz MS, Jessop DS. Orexin Expression and Function: Glucocorticoid Manipulation, Stress, and Feeding Studies. Endocrinology 2005;146:3724-31. [DOI: 10.1210/en.2005-0496] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
38 Székely M, Pétervári E, Balaskó M, Hernádi I, Uzsoki B. Effects of orexins on energy balance and thermoregulation. Regul Pept 2002;104:47-53. [PMID: 11830276 DOI: 10.1016/s0167-0115(01)00348-2] [Cited by in Crossref: 46] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
39 Cluderay JE, Harrison DC, Hervieu GJ. Protein distribution of the orexin-2 receptor in the rat central nervous system. Regul Pept 2002;104:131-44. [PMID: 11830288 DOI: 10.1016/s0167-0115(01)00357-3] [Cited by in Crossref: 198] [Cited by in F6Publishing: 65] [Article Influence: 9.9] [Reference Citation Analysis]
40 Higa Y, Kashiwadani H, Sugimura M, Kuwaki T. Orexinergic descending inhibitory pathway mediates linalool odor-induced analgesia in mice. Sci Rep 2021;11:9224. [PMID: 33927235 DOI: 10.1038/s41598-021-88359-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
41 Kukkonen JP, Holmqvist T, Ammoun S, Åkerman KEO. Functions of the orexinergic/hypocretinergic system. American Journal of Physiology-Cell Physiology 2002;283:C1567-91. [DOI: 10.1152/ajpcell.00055.2002] [Cited by in Crossref: 200] [Cited by in F6Publishing: 188] [Article Influence: 10.0] [Reference Citation Analysis]
42 Ciriello J, Caverson MM, Li Z. Effects of hypocretin and norepinephrine interaction in bed nucleus of the stria terminalis on arterial pressure. Neuroscience 2013;255:278-91. [PMID: 24070630 DOI: 10.1016/j.neuroscience.2013.09.032] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
43 Xu R, Wang Q, Yan M, Hernandez M, Gong C, Boon WC, Murata Y, Ueta Y, Chen C. Orexin-A augments voltage-gated Ca2+ currents and synergistically increases growth hormone (GH) secretion with GH-releasing hormone in primary cultured ovine somatotropes. Endocrinology 2002;143:4609-19. [PMID: 12446588 DOI: 10.1210/en.2002-220506] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 1.5] [Reference Citation Analysis]
44 Berridge CW, España RA, Vittoz NM. Hypocretin/orexin in arousal and stress. Brain Res 2010;1314:91-102. [PMID: 19748490 DOI: 10.1016/j.brainres.2009.09.019] [Cited by in Crossref: 115] [Cited by in F6Publishing: 115] [Article Influence: 8.8] [Reference Citation Analysis]
45 Kuwaki T. Orexin links emotional stress to autonomic functions. Autonomic Neuroscience 2011;161:20-7. [DOI: 10.1016/j.autneu.2010.08.004] [Cited by in Crossref: 59] [Cited by in F6Publishing: 59] [Article Influence: 5.4] [Reference Citation Analysis]
46 Grafe LA, Bhatnagar S. The contribution of orexins to sex differences in the stress response. Brain Res 2020;1731:145893. [PMID: 30081036 DOI: 10.1016/j.brainres.2018.07.026] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
47 Nixon JP, Smale L. A comparative analysis of the distribution of immunoreactive orexin A and B in the brains of nocturnal and diurnal rodents. Behav Brain Funct 2007;3:28. [PMID: 17567902 DOI: 10.1186/1744-9081-3-28] [Cited by in Crossref: 88] [Cited by in F6Publishing: 86] [Article Influence: 5.9] [Reference Citation Analysis]
48 Kuwaki T. Thermoregulation under pressure: a role for orexin neurons. Temperature (Austin) 2015;2:379-91. [PMID: 27227052 DOI: 10.1080/23328940.2015.1066921] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 3.1] [Reference Citation Analysis]
49 Rachalski A, Alexandre C, Bernard JF, Saurini F, Lesch KP, Hamon M, Adrien J, Fabre V. Altered sleep homeostasis after restraint stress in 5-HTT knock-out male mice: a role for hypocretins. J Neurosci 2009;29:15575-85. [PMID: 20007481 DOI: 10.1523/JNEUROSCI.3138-09.2009] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
50 Johnson PL, Molosh A, Fitz SD, Truitt WA, Shekhar A. Orexin, stress, and anxiety/panic states. Prog Brain Res 2012;198:133-61. [PMID: 22813973 DOI: 10.1016/B978-0-444-59489-1.00009-4] [Cited by in Crossref: 125] [Cited by in F6Publishing: 69] [Article Influence: 12.5] [Reference Citation Analysis]
51 Spinazzi R, Andreis PG, Rossi GP, Nussdorfer GG. Orexins in the regulation of the hypothalamic-pituitary-adrenal axis. Pharmacol Rev. 2006;58:46-57. [PMID: 16507882 DOI: 10.1124/pr.58.1.4] [Cited by in Crossref: 112] [Cited by in F6Publishing: 107] [Article Influence: 7.0] [Reference Citation Analysis]
52 de Lecea L, Sutcliffe JG, Fabre V. Hypocretins/orexins as integrators of physiological information: lessons from mutant animals. Neuropeptides 2002;36:85-95. [PMID: 12359500 DOI: 10.1054/npep.2002.0892] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 2.2] [Reference Citation Analysis]
53 Li J, Hu Z, de Lecea L. The hypocretins/orexins: integrators of multiple physiological functions. Br J Pharmacol 2014;171:332-50. [PMID: 24102345 DOI: 10.1111/bph.12415] [Cited by in Crossref: 153] [Cited by in F6Publishing: 141] [Article Influence: 19.1] [Reference Citation Analysis]
54 de Oliveira CV, Rosas-Arellano MP, Solano-Flores LP, Ciriello J. Cardiovascular effects of hypocretin-1 in nucleus of the solitary tract. Am J Physiol Heart Circ Physiol 2003;284:H1369-77. [PMID: 12531738 DOI: 10.1152/ajpheart.00877.2002] [Cited by in Crossref: 51] [Cited by in F6Publishing: 50] [Article Influence: 2.6] [Reference Citation Analysis]
55 Vittoz NM, Berridge CW. Hypocretin/orexin selectively increases dopamine efflux within the prefrontal cortex: involvement of the ventral tegmental area. Neuropsychopharmacology 2006;31:384-95. [PMID: 15988471 DOI: 10.1038/sj.npp.1300807] [Cited by in Crossref: 123] [Cited by in F6Publishing: 126] [Article Influence: 7.7] [Reference Citation Analysis]
56 Samson WK, Taylor MM, Follwell M, Ferguson AV. Orexin actions in hypothalamic paraventricular nucleus: physiological consequences and cellular correlates. Regul Pept 2002;104:97-103. [PMID: 11830283 DOI: 10.1016/s0167-0115(01)00353-6] [Cited by in Crossref: 92] [Cited by in F6Publishing: 34] [Article Influence: 4.6] [Reference Citation Analysis]
57 Telegdy G, Adamik A. The action of orexin A on passive avoidance learning. Involvement of transmitters. Regul Pept 2002;104:105-10. [PMID: 11830284 DOI: 10.1016/s0167-0115(01)00341-x] [Cited by in Crossref: 66] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
58 Boutrel B. A neuropeptide-centric view of psychostimulant addiction. Br J Pharmacol 2008;154:343-57. [PMID: 18414383 DOI: 10.1038/bjp.2008.133] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 2.4] [Reference Citation Analysis]
59 Heinonen MV, Purhonen AK, Mäkelä KA, Herzig KH. Functions of orexins in peripheral tissues. Acta Physiol (Oxf) 2008;192:471-85. [PMID: 18294339 DOI: 10.1111/j.1748-1716.2008.01836.x] [Cited by in Crossref: 125] [Cited by in F6Publishing: 115] [Article Influence: 8.9] [Reference Citation Analysis]
60 Weintraub A, Singaravelu J, Bhatnagar S. Enduring and sex-specific effects of adolescent social isolation in rats on adult stress reactivity. Brain Res 2010;1343:83-92. [PMID: 20438720 DOI: 10.1016/j.brainres.2010.04.068] [Cited by in Crossref: 116] [Cited by in F6Publishing: 109] [Article Influence: 9.7] [Reference Citation Analysis]
61 Ciriello J, Rosas-arellano M, Solano-flores L, de Oliveira CV. Identification of neurons containing orexin-B (hypocretin-2) immunoreactivity in limbic structures. Brain Research 2003;967:123-31. [DOI: 10.1016/s0006-8993(02)04233-6] [Cited by in Crossref: 30] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
62 Rohleder N, Kirschbaum C. Effects of nutrition on neuro-endocrine stress responses: . Current Opinion in Clinical Nutrition and Metabolic Care 2007;10:504-10. [DOI: 10.1097/mco.0b013e3281e38808] [Cited by in Crossref: 25] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
63 Nevsimalova S. Narcolepsy in childhood. Sleep Medicine Reviews 2009;13:169-80. [DOI: 10.1016/j.smrv.2008.04.007] [Cited by in Crossref: 65] [Cited by in F6Publishing: 54] [Article Influence: 5.0] [Reference Citation Analysis]
64 Martin-Fardon R, Zorrilla EP, Ciccocioppo R, Weiss F. Role of innate and drug-induced dysregulation of brain stress and arousal systems in addiction: Focus on corticotropin-releasing factor, nociceptin/orphanin FQ, and orexin/hypocretin. Brain Res 2010;1314:145-61. [PMID: 20026088 DOI: 10.1016/j.brainres.2009.12.027] [Cited by in Crossref: 75] [Cited by in F6Publishing: 73] [Article Influence: 5.8] [Reference Citation Analysis]
65 Jászberényi M, Bujdosó E, Kiss E, Pataki I, Telegdy G. The role of NPY in the mediation of orexin-induced hypothermia. Regulatory Peptides 2002;104:55-9. [DOI: 10.1016/s0167-0115(01)00339-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
66 Bonnavion P, Jackson AC, Carter ME, de Lecea L. Antagonistic interplay between hypocretin and leptin in the lateral hypothalamus regulates stress responses. Nat Commun 2015;6:6266. [PMID: 25695914 DOI: 10.1038/ncomms7266] [Cited by in Crossref: 91] [Cited by in F6Publishing: 86] [Article Influence: 13.0] [Reference Citation Analysis]
67 Goadsby PJ, Holland PR, Martins-Oliveira M, Hoffmann J, Schankin C, Akerman S. Pathophysiology of Migraine: A Disorder of Sensory Processing. Physiol Rev 2017;97:553-622. [PMID: 28179394 DOI: 10.1152/physrev.00034.2015] [Cited by in Crossref: 570] [Cited by in F6Publishing: 485] [Article Influence: 114.0] [Reference Citation Analysis]
68 Sanford LD, Suchecki D, Meerlo P. Stress, Arousal, and Sleep. In: Meerlo P, Benca RM, Abel T, editors. Sleep, Neuronal Plasticity and Brain Function. Berlin: Springer Berlin Heidelberg; 2015. pp. 379-410. [DOI: 10.1007/7854_2014_314] [Cited by in Crossref: 65] [Cited by in F6Publishing: 54] [Article Influence: 8.1] [Reference Citation Analysis]
69 Steiner MA, Sciarretta C, Brisbare-Roch C, Strasser DS, Studer R, Jenck F. Examining the role of endogenous orexins in hypothalamus-pituitary-adrenal axis endocrine function using transient dual orexin receptor antagonism in the rat. Psychoneuroendocrinology 2013;38:560-71. [PMID: 22917622 DOI: 10.1016/j.psyneuen.2012.07.016] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
70 D’souza MS, Markou A. Neural Substrates of Psychostimulant Withdrawal-Induced Anhedonia. In: Self DW, Staley Gottschalk JK, editors. Behavioral Neuroscience of Drug Addiction. Berlin: Springer Berlin Heidelberg; 2010. pp. 119-78. [DOI: 10.1007/7854_2009_20] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 2.8] [Reference Citation Analysis]
71 Kurose T, Ueta Y, Yamamoto Y, Serino R, Ozaki Y, Saito J, Nagata S, Yamashita H. Effects of restricted feeding on the activity of hypothalamic Orexin (OX)-A containing neurons and OX2 receptor mRNA level in the paraventricular nucleus of rats. Regul Pept 2002;104:145-51. [PMID: 11830289 DOI: 10.1016/s0167-0115(01)00340-8] [Cited by in Crossref: 41] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
72 Ferguson AV, Samson WK. The orexin/hypocretin system: a critical regulator of neuroendocrine and autonomic function. Frontiers in Neuroendocrinology 2003;24:141-50. [DOI: 10.1016/s0091-3022(03)00028-1] [Cited by in Crossref: 133] [Cited by in F6Publishing: 38] [Article Influence: 7.0] [Reference Citation Analysis]
73 Ciriello J, de Oliveira CV. Cardiac effects of hypocretin-1 in nucleus ambiguus. Am J Physiol Regul Integr Comp Physiol 2003;284:R1611-20. [PMID: 12573979 DOI: 10.1152/ajpregu.00719.2002] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 2.1] [Reference Citation Analysis]
74 Kagerer SM, Jöhren O. Interactions of orexins/hypocretins with adrenocortical functions. Acta Physiol (Oxf) 2010;198:361-71. [PMID: 19719797 DOI: 10.1111/j.1748-1716.2009.02034.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
75 Gamble MC, Katsuki F, McCoy JG, Strecker RE, McKenna JT. The Dual Orexin Receptor Antagonist DORA-22 Improves Mild Stress-induced Sleep Disruption During the Natural Sleep Phase of Nocturnal Rats. Neuroscience 2021;463:30-44. [PMID: 33737028 DOI: 10.1016/j.neuroscience.2021.03.003] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
76 Boutrel B, Kenny PJ, Markou A, Koob GF. Hypocretin and Brain Reward Function. In: de Lecea L, Sutcliffe JG, editors. Hypocretins. Boston: Springer US; 2005. pp. 317-26. [DOI: 10.1007/0-387-25446-3_21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
77 Kirchgessner AL. Orexins in the brain-gut axis. Endocr Rev. 2002;23:1-15. [PMID: 11844742 DOI: 10.1210/edrv.23.1.0454] [Cited by in Crossref: 70] [Cited by in F6Publishing: 63] [Article Influence: 3.5] [Reference Citation Analysis]
78 Zhu L, Onaka T, Sakurai T, Yada T. Activation of orexin neurones after noxious but not conditioned fear stimuli in rats. Neuroreport 2002;13:1351-3. [PMID: 12151801 DOI: 10.1097/00001756-200207190-00027] [Cited by in Crossref: 49] [Cited by in F6Publishing: 42] [Article Influence: 2.5] [Reference Citation Analysis]
79 Grafe LA, Bhatnagar S. Orexins and stress. Front Neuroendocrinol 2018;51:132-45. [PMID: 29932958 DOI: 10.1016/j.yfrne.2018.06.003] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 8.5] [Reference Citation Analysis]
80 Guan JL, Uehara K, Lu S, Wang QP, Funahashi H, Sakurai T, Yanagizawa M, Shioda S. Reciprocal synaptic relationships between orexin- and melanin-concentrating hormone-containing neurons in the rat lateral hypothalamus: a novel circuit implicated in feeding regulation. Int J Obes Relat Metab Disord 2002;26:1523-32. [PMID: 12461668 DOI: 10.1038/sj.ijo.0802155] [Cited by in Crossref: 94] [Cited by in F6Publishing: 87] [Article Influence: 4.9] [Reference Citation Analysis]
81 Steckler T. Chapter 4.1 Peptide receptor ligands to treat anxiety disorders. Handbook of Anxiety and Fear. Elsevier; 2008. pp. 157-221. [DOI: 10.1016/s1569-7339(07)00010-0] [Cited by in Crossref: 6] [Article Influence: 0.4] [Reference Citation Analysis]
82 Kim AK, Brown RM, Lawrence AJ. The role of orexins/hypocretins in alcohol use and abuse: an appetitive-reward relationship. Front Behav Neurosci 2012;6:78. [PMID: 23189046 DOI: 10.3389/fnbeh.2012.00078] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
83 Fujisawa S, Komatsubara M, Tsukamoto-Yamauchi N, Iwata N, Nada T, Wada J, Otsuka F. Orexin A Enhances Pro-Opiomelanocortin Transcription Regulated by BMP-4 in Mouse Corticotrope AtT20 Cells. Int J Mol Sci 2021;22:4553. [PMID: 33925368 DOI: 10.3390/ijms22094553] [Reference Citation Analysis]
84 Kiwaki K, Kotz CM, Wang C, Lanningham-Foster L, Levine JA. Orexin A (hypocretin 1) injected into hypothalamic paraventricular nucleus and spontaneous physical activity in rats. Am J Physiol Endocrinol Metab 2004;286:E551-9. [PMID: 14656716 DOI: 10.1152/ajpendo.00126.2003] [Cited by in Crossref: 105] [Cited by in F6Publishing: 98] [Article Influence: 5.5] [Reference Citation Analysis]
85 Grafe LA, Eacret D, Dobkin J, Bhatnagar S. Reduced Orexin System Function Contributes to Resilience to Repeated Social Stress. eNeuro 2018;5:ENEURO. [PMID: 29662948 DOI: 10.1523/ENEURO.0273-17.2018] [Cited by in Crossref: 33] [Cited by in F6Publishing: 15] [Article Influence: 8.3] [Reference Citation Analysis]
86 Singareddy R, Uhde T, Commissaris R. Differential effects of hypocretins on noise-alone versus potentiated startle responses. Physiol Behav 2006;89:650-5. [PMID: 17028045 DOI: 10.1016/j.physbeh.2006.08.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
87 Kuwaki T. Orexin (hypocretin) participates in central autonomic regulation during fight-or-flight response. Peptides 2021;139:170530. [PMID: 33741478 DOI: 10.1016/j.peptides.2021.170530] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
88 Parameswaran G, Ray DW. Sleep, circadian rhythms, and type 2 diabetes mellitus. Clin Endocrinol (Oxf) 2021. [PMID: 34637144 DOI: 10.1111/cen.14607] [Reference Citation Analysis]
89 Fenzl T, Romanowski CP, Flachskamm C, Deussing JM, Kimura M. Wake-promoting effects of orexin: Its independent actions against the background of an impaired corticotropine-releasing hormone receptor system. Behav Brain Res 2011;222:43-50. [PMID: 21420442 DOI: 10.1016/j.bbr.2011.03.026] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
90 Martins PJ, D'Almeida V, Pedrazzoli M, Lin L, Mignot E, Tufik S. Increased hypocretin-1 (orexin-a) levels in cerebrospinal fluid of rats after short-term forced activity. Regul Pept 2004;117:155-8. [PMID: 14749034 DOI: 10.1016/j.regpep.2003.10.003] [Cited by in Crossref: 68] [Cited by in F6Publishing: 63] [Article Influence: 3.8] [Reference Citation Analysis]
91 D'Anna KL, Gammie SC. Hypocretin-1 dose-dependently modulates maternal behaviour in mice. J Neuroendocrinol 2006;18:553-66. [PMID: 16867176 DOI: 10.1111/j.1365-2826.2006.01448.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 2.0] [Reference Citation Analysis]
92 Chen C, Xu R. The In Vitro Regulation of Growth Hormone Secretion by Orexins. ENDO 2003;22:57-66. [DOI: 10.1385/endo:22:1:57] [Cited by in Crossref: 14] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
93 Li Y, Li S, Wei C, Wang H, Sui N, Kirouac GJ. Orexins in the paraventricular nucleus of the thalamus mediate anxiety-like responses in rats. Psychopharmacology (Berl) 2010;212:251-65. [PMID: 20645079 DOI: 10.1007/s00213-010-1948-y] [Cited by in Crossref: 113] [Cited by in F6Publishing: 113] [Article Influence: 9.4] [Reference Citation Analysis]
94 Katayama A, Kanada Y, Tsukada M, Akanuma Y, Takemura H, Ono T, Suga H, Mera H, Hisamitsu T, Sunagawa M. Yokukansan (Kampo medicinal formula) prevents the development of morphine tolerance by inhibiting the secretion of orexin A. Integr Med Res 2018;7:141-8. [PMID: 29989049 DOI: 10.1016/j.imr.2018.02.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
95 Kuwaki T, Zhang W. Orexin neurons and emotional stress. Vitam Horm 2012;89:135-58. [PMID: 22640612 DOI: 10.1016/B978-0-12-394623-2.00008-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
96 Tsunematsu T, Yamanaka A. The Role of Orexin/Hypocretin in the Central Nervous System and Peripheral Tissues. Sleep Hormones. Elsevier; 2012. pp. 19-33. [DOI: 10.1016/b978-0-12-394623-2.00002-0] [Cited by in Crossref: 25] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
97 Levine AS, Winsky-sommerer R, Huitron-resendiz S, Grace MK, de Lecea L. Injection of neuropeptide W into paraventricular nucleus of hypothalamus increases food intake. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 2005;288:R1727-32. [DOI: 10.1152/ajpregu.00638.2003] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 2.0] [Reference Citation Analysis]
98 de Oliveira CV, Ciriello J. Cardiovascular responses to hypocretin-1 in nucleus ambiguus of the ovariectomized female rat. Brain Res 2003;986:148-56. [PMID: 12965239 DOI: 10.1016/s0006-8993(03)03226-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
99 Sakamoto F, Yamada S, Ueta Y. Centrally administered orexin-A activates corticotropin-releasing factor-containing neurons in the hypothalamic paraventricular nucleus and central amygdaloid nucleus of rats: possible involvement of central orexins on stress-activated central CRF neurons. Regul Pept 2004;118:183-91. [PMID: 15003835 DOI: 10.1016/j.regpep.2003.12.014] [Cited by in Crossref: 121] [Cited by in F6Publishing: 115] [Article Influence: 7.1] [Reference Citation Analysis]
100 Hungs M, Mignot E. Hypocretin/orexin, sleep and narcolepsy. Bioessays 2001;23:397-408. [DOI: 10.1002/bies.1058] [Cited by in Crossref: 87] [Cited by in F6Publishing: 79] [Article Influence: 4.1] [Reference Citation Analysis]
101 Kokare DM, Patole AM, Carta A, Chopde CT, Subhedar NK. GABAA receptors mediate orexin-A induced stimulation of food intake. Neuropharmacology 2006;50:16-24. [DOI: 10.1016/j.neuropharm.2005.07.019] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 1.6] [Reference Citation Analysis]
102 Patel AX, Miller SR, Nathan PJ, Kanakaraj P, Napolitano A, Lawrence P, Koch A, Bullmore ET. Neuroendocrine and sympathetic responses to an orexin receptor antagonist, SB-649868, and alprazolam following insulin-induced hypoglycemia in humans. Psychopharmacology (Berl) 2014;231:3817-28. [PMID: 24770625 DOI: 10.1007/s00213-014-3520-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
103 Chen Q, de Lecea L, Hu Z, Gao D. The hypocretin/orexin system: an increasingly important role in neuropsychiatry. Med Res Rev 2015;35:152-97. [PMID: 25044006 DOI: 10.1002/med.21326] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 5.5] [Reference Citation Analysis]
104 Taylor MM, Samson WK. The other side of the orexins: endocrine and metabolic actions. American Journal of Physiology-Endocrinology and Metabolism 2003;284:E13-7. [DOI: 10.1152/ajpendo.00359.2002] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 2.2] [Reference Citation Analysis]
105 Samson WK, Bagley SL, Ferguson AV, White MM. Hypocretin/orexin type 1 receptor in brain: role in cardiovascular control and the neuroendocrine response to immobilization stress. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 2007;292:R382-7. [DOI: 10.1152/ajpregu.00496.2006] [Cited by in Crossref: 50] [Cited by in F6Publishing: 55] [Article Influence: 3.3] [Reference Citation Analysis]
106 Nguyen PH, Greene E, Kong BW, Bottje W, Anthony N, Dridi S. Acute Heat Stress Alters the Expression of Orexin System in Quail Muscle. Front Physiol 2017;8:1079. [PMID: 29311994 DOI: 10.3389/fphys.2017.01079] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
107 Salomon RM, Ripley B, Kennedy JS, Johnson B, Schmidt D, Zeitzer JM, Nishino S, Mignot E. Diurnal variation of cerebrospinal fluid hypocretin-1 (Orexin-A) levels in control and depressed subjects. Biol Psychiatry. 2003;54:96-104. [PMID: 12873798 DOI: 10.1016/s0006-3223(02)01740-7] [Cited by in Crossref: 173] [Cited by in F6Publishing: 72] [Article Influence: 9.1] [Reference Citation Analysis]
108 Samson WK, Taylor MM. Hypocretin/orexin suppresses corticotroph responsiveness in vitro. Am J Physiol Regul Integr Comp Physiol 2001;281:R1140-5. [PMID: 11557621 DOI: 10.1152/ajpregu.2001.281.4.R1140] [Cited by in Crossref: 45] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
109 Girault EM, Foppen E, Ackermans MT, Fliers E, Kalsbeek A. Central administration of an orexin receptor 1 antagonist prevents the stimulatory effect of Olanzapine on endogenous glucose production. Brain Research 2013;1527:238-45. [DOI: 10.1016/j.brainres.2013.06.034] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
110 Smart D, Jerman JC. The physiology and pharmacology of the orexins. Pharmacology & Therapeutics 2002;94:51-61. [DOI: 10.1016/s0163-7258(02)00171-7] [Cited by in Crossref: 69] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
111 Iwasa T, Matsuzaki T, Kiyokawa M, Shimizu F, Minakuchi M, Kuwahara A, Maegawa M, Yasui T, Irahara M. The type 2 corticotrophin-releasing hormone receptor mediates orexin A-induced luteinising hormone suppression in ovariectomised rats. J Neuroendocrinol 2007;19:732-8. [PMID: 17680889 DOI: 10.1111/j.1365-2826.2007.01583.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
112 Richards JK, Simms JA, Steensland P, Taha SA, Borgland SL, Bonci A, Bartlett SE. Inhibition of orexin-1/hypocretin-1 receptors inhibits yohimbine-induced reinstatement of ethanol and sucrose seeking in Long-Evans rats. Psychopharmacology (Berl) 2008;199:109-17. [PMID: 18470506 DOI: 10.1007/s00213-008-1136-5] [Cited by in Crossref: 166] [Cited by in F6Publishing: 178] [Article Influence: 11.9] [Reference Citation Analysis]
113 Balkan B, Pogun S. Nicotinic Cholinergic System in the Hypothalamus Modulates the Activity of the Hypothalamic Neuropeptides During the Stress Response. Curr Neuropharmacol 2018;16:371-87. [PMID: 28730966 DOI: 10.2174/1570159X15666170720092442] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.8] [Reference Citation Analysis]
114 López M, Tena-sempere M, García-caballero T, Señarís R, Diéguez C. Hypocretins in Endocrine Regulation. In: de Lecea L, Sutcliffe JG, editors. Hypocretins. Boston: Springer US; 2005. pp. 395-423. [DOI: 10.1007/0-387-25446-3_27] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
115 Hsiao YT, Jou SB, Yi PL, Chang FC. Activation of GABAergic pathway by hypocretin in the median raphe nucleus (MRN) mediates stress-induced theta rhythm in rats. Behav Brain Res 2012;233:224-31. [PMID: 22579972 DOI: 10.1016/j.bbr.2012.05.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
116 Sharf R, Sarhan M, Dileone RJ. Role of orexin/hypocretin in dependence and addiction. Brain Res 2010;1314:130-8. [PMID: 19699189 DOI: 10.1016/j.brainres.2009.08.028] [Cited by in Crossref: 73] [Cited by in F6Publishing: 72] [Article Influence: 5.6] [Reference Citation Analysis]
117 Ahmadi-soleimani SM, Mianbandi V, Azizi H, Azhdari-zarmehri H, Ghaemi-jandabi M, Abbasi-mazar A, Mohajer Y, Darana SP. Coregulation of sleep-pain physiological interplay by orexin system: An unprecedented review. Behavioural Brain Research 2020;391:112650. [DOI: 10.1016/j.bbr.2020.112650] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
118 Winsky-Sommerer R, Yamanaka A, Diano S, Borok E, Roberts AJ, Sakurai T, Kilduff TS, Horvath TL, de Lecea L. Interaction between the corticotropin-releasing factor system and hypocretins (orexins): a novel circuit mediating stress response. J Neurosci 2004;24:11439-48. [PMID: 15601950 DOI: 10.1523/JNEUROSCI.3459-04.2004] [Cited by in Crossref: 288] [Cited by in F6Publishing: 148] [Article Influence: 16.9] [Reference Citation Analysis]
119 Reppucci CJ, Gergely CK, Bredewold R, Veenema AH. Involvement of orexin/hypocretin in the expression of social play behaviour in juvenile rats. Int J Play 2020;9:108-27. [PMID: 33042634 DOI: 10.1080/21594937.2020.1720132] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
120 Gamble MC, Katsuki F, Mccoy JG, Strecker RE, Mckenna JT. The dual orexinergic receptor antagonist DORA-22 improves the sleep disruption and memory impairment produced by a rodent insomnia model. Sleep 2019. [DOI: 10.1093/sleep/zsz241] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
121 de Oliveira CV, Rosas-arellano M, Solano-flores L, Babic T, Li Z, Ciriello J. Estrogen alters the bradycardia response to hypocretin-1 in the nucleus tractus solitarius of the ovariectomized female. Brain Research 2003;978:14-23. [DOI: 10.1016/s0006-8993(03)02724-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
122 Moreno G, Perelló M, Gaillard RC, Spinedi E. Orexin a stimulates hypothalamic-pituitary-adrenal (HPA) axis function, but not food intake, in the absence of full hypothalamic NPY-ergic activity. Endocrine 2005;26:99-106. [PMID: 15888921 DOI: 10.1385/ENDO:26:2:099] [Cited by in Crossref: 23] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
123 Samson WK, Bagley SL, Ferguson AV, White MM. Orexin receptor subtype activation and locomotor behaviour in the rat. Acta Physiol (Oxf) 2010;198:313-24. [PMID: 19889100 DOI: 10.1111/j.1748-1716.2009.02056.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
124 López M, Seoane LM, Tovar S, Nogueiras R, Diéguez C, Señarís R. Orexin-A regulates growth hormone-releasing hormone mRNA content in a nucleus-specific manner and somatostatin mRNA content in a growth hormone-dependent fashion in the rat hypothalamus. Eur J Neurosci 2004;19:2080-8. [PMID: 15090035 DOI: 10.1111/j.0953-816X.2004.03318.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
125 Brunton PJ, Russell JA. Hypothalamic-pituitary-adrenal responses to centrally administered orexin-A are suppressed in pregnant rats. J Neuroendocrinol 2003;15:633-7. [PMID: 12787047 DOI: 10.1046/j.1365-2826.2003.01045.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 2.5] [Reference Citation Analysis]
126 Ciriello J, Li Z, de Oliveira CV. Cardioacceleratory responses to hypocretin-1 injections into rostral ventromedial medulla. Brain Research 2003;991:84-95. [DOI: 10.1016/j.brainres.2003.08.008] [Cited by in Crossref: 63] [Cited by in F6Publishing: 64] [Article Influence: 3.3] [Reference Citation Analysis]
127 Beck B, Richy S, Dimitrov T, Stricker-Krongrad A. Opposite regulation of hypothalamic orexin and neuropeptide Y receptors and peptide expressions in obese Zucker rats. Biochem Biophys Res Commun. 2001;286:518-523. [PMID: 11511089 DOI: 10.1006/bbrc.2001.5420] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 2.1] [Reference Citation Analysis]
128 Zhou L, Sun WL, See RE. Orexin Receptor Targets for Anti-Relapse Medication Development in Drug Addiction. Pharmaceuticals (Basel) 2011;4:804-21. [PMID: 23997653 DOI: 10.3390/ph4060804] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
129 Jászberényi M, Bujdosó E, Telegdy G. The role of neuropeptide Y in orexin-induced hypothalamic-pituitary-adrenal activation. J Neuroendocrinol 2001;13:438-41. [PMID: 11328454 DOI: 10.1046/j.1365-2826.2001.00654.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 1.6] [Reference Citation Analysis]
130 Ciriello J, Caverson MM, McMurray JC, Bruckschwaiger EB. Co-localization of hypocretin-1 and leucine-enkephalin in hypothalamic neurons projecting to the nucleus of the solitary tract and their effect on arterial pressure. Neuroscience 2013;250:599-613. [PMID: 23912034 DOI: 10.1016/j.neuroscience.2013.07.054] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
131 Palotai M, Telegdy G, Ekwerike A, Jászberényi M. The action of orexin B on passive avoidance learning. Involvement of neurotransmitters. Behav Brain Res 2014;272:1-7. [PMID: 24931796 DOI: 10.1016/j.bbr.2014.06.016] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
132 Ueta Y, Ozaki Y, Saito J, Onaka T. Involvement of Novel Feeding-Related Peptides in Neuroendocrine Response to Stress. Exp Biol Med (Maywood) 2016;228:1168-74. [DOI: 10.1177/153537020322801011] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.8] [Reference Citation Analysis]
133 Hata T, Chen J, Ebihara K, Date Y, Ishida Y, Nakahara D. Intra-ventral tegmental area or intracerebroventricular orexin-A increases the intra-cranial self-stimulation threshold via activation of the corticotropin-releasing factor system in rats. Eur J Neurosci 2011;34:816-26. [PMID: 21848921 DOI: 10.1111/j.1460-9568.2011.07808.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
134 Samson WK, Taylor MM, Ferguson AV. Non-sleep effects of hypocretin/orexin. Sleep Med Rev 2005;9:243-52. [PMID: 16036174 DOI: 10.1016/j.smrv.2004.07.006] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 2.8] [Reference Citation Analysis]